Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium
van Kampen, R.J.W, Ramaekers, B.L.T, Lobbezoo, D.J.A, de Boer, M, Dercksen, M.W, van den Berkmortel, F, Smilde, T.J, van de Wouw, A.J, Peters, F.P.J, van Riel, J.M.G, Peters, N.A.J.B, Tjan-Heijnen, V.C.G, Joore, M.A
Published in European journal of cancer (1990) (01.07.2017)
Published in European journal of cancer (1990) (01.07.2017)
Get full text
Journal Article
Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial
van der Kruijssen, Dave E. W, Elias, Sjoerd G, Vink, Geraldine R, van Rooijen, Karlijn L, ‘t Lam-Boer, Jorine, Mol, Linda, Punt, Cornelis J. A, de Wilt, Johannes H. W, Koopman, Miriam
Published in JAMA surgery (01.12.2021)
Published in JAMA surgery (01.12.2021)
Get full text
Journal Article
A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium
van Kampen, R.J.W., Lobbezoo, D.J.A., de Boer, M., Dercksen, M.W., Voogd, A.C., van den Berkmortel, F., Smilde, T.J., van de Wouw, A.J., Peters, F.P.J., van Riel, J.M.G., Peters, N.A.J.B., Peer, P.G.M., Joore, M.A., Tjan-Heijnen, V.C.G.
Published in Cancer treatment and research communications (2017)
Published in Cancer treatment and research communications (2017)
Get full text
Journal Article